Phenotypic and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli in Bangladesh

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lina, Taslima T ^a   Khajanchi, Bijay K ^a   Azmi, Ishrat J ^a   Islam, Mohammad Aminul ^a   Mahmood, Belal ^a   Akter, Mahmuda ^a   Banik, Atanu ^a   Alim, Rumana ^a   Navarro, Armando ^b   Perez, Gabriel ^b   Cravioto, Alejandro ^a   Talukder, Kaisar A ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE CTX M1; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; NALIDIXIC ACID; PLASMID DNA; UNCLASSIFIED DRUG; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BANGLADESH; BLACTX M 1 GENE; BLAOXA 1 GENE; BLATEM GENE; CELL CLONE; CONTROLLED STUDY; DIARRHEAGENIC ESCHERICHIA COLI; DISK DIFFUSION; ENZYME SYNTHESIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HOSPITAL; HUMAN; INTEGRON; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RURAL AREA; SEQUENCE ANALYSIS; SEROTYPING; URBAN AREA; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; WOUND INFECTION; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

ESCHERICHIA COLI;

BANGLADESH; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; HUMANS; PHENOTYPE;

EID: 84907856555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108735     Document Type: Article

References (50)

1. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11: 315-317.
2. Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14: 933-951, table of contents.
3. Bush K (2001) New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32: 1085-1089.
4. Coudron PE, Moland ES, Sanders CC (1997) Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 35: 2593-2597.
5. Dashti AA, West P, Paton R, Amyes SG (2006) Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains. J Med Microbiol 55: 417-421.
6. Hernandez JR, Martinez-Martinez L, Canton R, Coque TM, Pascual A (2005) Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother 49: 2122-2125.
7. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, et al. (2006) CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 50: 2700-2706.
8. Radice M, Power P, Di Conza J, Gutkind G (2002) Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 46: 602-604.
9. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, et al. (2009) Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63: 72-79.
10. Canton R, Coque TM, Baquero F (2003) Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis 16: 315-325.
11. Fang H, Ataker F, Hedin G, Dornbusch K (2008) Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 46: 707-712.
12. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, et al. (2005) Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 56: 698-702.
13. Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD (2005) Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother 56: 236-239.
14. Mehrgan H, Rahbar M (2008) Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 31: 147-151.
15. Rahman MM, Haq JA, Hossain MA, Sultana R, Islam F, et al. (2004) Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh. Int J Antimicrob Agents 24: 508-510.
16. Forbes BA SD, Weissfeld AS (2001) Overview of conventional methods for bacterial identification. In: Edmiston CE, editor. Bailey and Scott's Diagnostic Microbiology. St Loius, MO:Elsevier Health Sciences.
17. CLSI (2010) Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M100-S20-U, 20th Informational Supplement (June 2010, Update). Wayne, PA: Clinical and Laboratory Standards Institute.
18. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10: 867-878.
19. Heuvelink AE DBE, Wernars K (1994) Detection of Escherichia coli 0157:H7 in raw beef by polymerase chain reaction. De ware Chemicus 24: 25-43.
20. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, et al. (1998) beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 42: 1350-1354.
21. Guerra B, Soto SM, Argüelles JM (2001) Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-]. Antimicrob Agents Chemother 45: 1305-8.
22. Muzaheed, Doi Y, Adams-Haduch JM, Endimiani A, Sidjabat HE, et al. (2008) High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 61: 1393-1394.
23. Vargas M, Gascon J, Jimenez De Anta MT, Vila J (1999) Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol 37: 3608-3611.
24. Chakraborty S, Deokule JS, Garg P, Bhattacharya SK, Nandy RK, et al. (2001) Concomitant infection of enterotoxigenic Escherichia coli in an outbreak of cholera caused by Vibrio cholerae O1 and O139 in Ahmedabad, India. J Clin Microbiol 39: 3241-6.
25. Islam MA, Talukdar PK, Hoque A, Huq M, Nabi A, et al. (2012) Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur J Clin Microbiol Infect Dis.31(10): 2593-600.
26. Talukder KA, Khajanchi BK, Islam MA, Islam Z, Dutta DK, et al. (2006) Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. Curr Microbiol 52: 108-111.
27. Lavilla S, Gonzalez-Lopez JJ, Sabate M, Garcia-Fernandez A, Larrosa MN, et al. (2008) Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J Antimicrob Chemother 61: 291-295.
28. Morgan-Linnell SK, Zechiedrich L (2007) Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 51: 4205-4208.
29. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
30. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882.
31. Ørskov F, Ørskov I (1984) Serotyping of Escherichia coli. In T. Bergan (Ed). Methods in Microbiology. Academic Press Ltd, London 14: 43-112.
32. Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145: 1365-1373.
33. Talukder KA, Islam MA, Dutta DK, Hassan F, Safa A, et al. (2002) Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. J Clin Microbiol 40: 2490-2497.
34. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, et al. (2005) Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 43: 1045-1050.
35. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
36. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, et al. (2008) UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62: 1241-1244.
37. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
38. Talukdar PK, Rahman M, Nabi A, Islam Z, Hoque MM, et al. (2013) Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PLoS One 8(4): e61090.
39. Prelog M, Fille M, Prodinger W, Grif K, Brunner A, et al. (2008) CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria. Infection 36: 362-367.
40. Hasan B, Islam K, Ahsan M, Hossain Z, Rashid M, et al. (2014) Fecal carriage of multi-drug resistant and extended spectrum beta-lactamases producing E. coli in household pigeons, Bangladesh. Vet Microbiol 168: 221-224.
41. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14.
42. Doublet B, Granier SA, Robin F, Bonnet R, Fabre L, et al. (2009) Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg. Antimicrob Agents Chemother 53: 1944-1951.
43. Liu W, Chen L, Li H, Duan H, Zhang Y, et al. (2009) Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 63: 895-900.
44. Boyd DA, Mulvey MR (2006) OXA-1 is OXA-30 is OXA-1. J Antimicrob Chemother 58: 224-225.
45. Carattoli A, Garcia-Fernandez A, Varesi P, Fortini D, Gerardi S, et al. (2008) Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol 46: 103-108.
46. Villa L, Pezzella C, Tosini F, Visca P, Petrucca A, et al. (2000) Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum beta-lactamase gene and a class 1 integron. Antimicrob Agents Chemother 44: 2911-2914.
47. Machado E, Canton R, Baquero F, Galan JC, Rollan A, et al. (2005) Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 49: 1823-1829.
48. Salyers AA WD (2005) Escherichia coli Gastrointestinal Infections. In: Bacterial Pathogenesis a Molecular Approach. Washington, D.C.
49. Jacoby GA, Sutton L (1991) Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob Agents Chemother 35: 164-169.
50. Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, et al. (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42: 4769-4775.